COVID-19 Prevalence and Antibody Seroprevalence Among Individuals with Intellectual Disability
COVID-19 Prevalence and Antibody Seroprevalence Among Individuals with Intellectual Disability
Tiffany Adams, Darlene Barnes, Jennifer Caputo, Dawn Diamond, Tine Hansen-Turton, Deborah Jones, Stephen Kolesk, Scott Spreat
ABSTRACT
Approximately 20% of the residential census at a population healthcare facility tested positive for COVID1-9 during the period from March 2020 through early June 2020. Individuals residing within the facility had intellectual disability, autism, and/or brain injury. Fifteen were hospitalized, but all subsequently were discharged. Two hospitalized clients died as a result of factors unrelated to COVID-19, and a third was pronounced dead upon arrival at the Emergency room, again as a result of factors unrelated to COVID-19. individuals died as a result of factors unrelated to COVID-19. Approximately ¾ of the infected clients developed antibodies within 28 days of initial diagnosis. The development of antibodies could not be predicted from readily available demographic or medical variables.